Recap: Lexicon Pharmaceuticals Q3 Earnings

Lexicon Pharmaceuticals LXRX reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM.

Here's what investors need to know about the announcement.

Lexicon Pharmaceuticals their estimated earnings by 11.11%, reporting an EPS of $-0.16 versus an estimate of $-0.18, which surprised analysts.

Revenue was up $6,611,000 from the same period last year.

Last quarter the company beat on EPS by $0.03, which was followed by a 1.12% drop in the share price the next day.

Here's a look at Lexicon Pharmaceuticals's past performance:

Quarter	Q2 2021	Q1 2021	Q4 2020	Q3 2020
EPS Estimate	-0.16	-0.16	-0.28	0.26
EPS Actual	-0.13	-0.15	-0.04	-0.43
Revenue Estimate	10.00K	1.68M	110.00K	16.87M
Revenue Actual	234.00K	27.00K	199.00K	6.63M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Earnings Calendar